Advances in the management of triple negative breast cancer:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London
Future Medicine Ltd
c2011
|
| Schriftenreihe: | Future Science Group eBook collection
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Beschreibung: | Includes bibliographical references and index Advances in the management of triple-negative breast cancer / Tiffany A. Traina & Clifford A. Hudis -- Etiology and risk factors / Laura Fejerman & Elad Ziv -- Diagnosis and pathology / Govardhanan Nagaiah & Jame Abraham -- Molecular subtypes and emerging therapeutic opportunities / Anastasia Constantinidou, Robin L. Jones & Jorge S. Reis-Filho -- Molecular profile of triple-negative breast cancer / Leonel F. Hernandez-Aya & Ana Maria Gonzalez-Angulo -- Role of metabolic rehabilitation-based approach in TNBC : biguanide metformin and more / Lev M. Berstein, Garik A. Dashyan & Vladimir F. Semiglazov -- Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer / Mark Robson -- Targeted therapies: EGFR inhibitors / Farrah M. Datko & Maura N. Dickler -- Targeted therapies : other agents in clinical trials / Brian R. Haney, Nathan M. Shumway & George E. Peoples -- Combined therapies and future directions / Anastasia Pazaiti & Ian S. Fentiman |
| Beschreibung: | 1 electronic text (107 p.) col. ill., digital file |
| ISBN: | 9781780840123 9781780840130 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV039836806 | ||
| 003 | DE-604 | ||
| 005 | 20121029 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 120124s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 9781780840123 |c eBook |9 978-1-78084-012-3 | ||
| 020 | |a 9781780840130 |9 978-1-78084-013-0 | ||
| 024 | 7 | |a 10.2217/9781780840123 |2 doi | |
| 035 | |a (OCoLC)759716165 | ||
| 035 | |a (DE-599)BVBBV039836806 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.99/449 |2 22 | |
| 084 | |a XH 8465 |0 (DE-625)152958:13144 |2 rvk | ||
| 245 | 1 | 0 | |a Advances in the management of triple negative breast cancer |c editors, Clifford A. Hudis ... |
| 264 | 1 | |a London |b Future Medicine Ltd |c c2011 | |
| 300 | |a 1 electronic text (107 p.) |b col. ill., digital file | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Future Science Group eBook collection | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Advances in the management of triple-negative breast cancer / Tiffany A. Traina & Clifford A. Hudis -- Etiology and risk factors / Laura Fejerman & Elad Ziv -- Diagnosis and pathology / Govardhanan Nagaiah & Jame Abraham -- Molecular subtypes and emerging therapeutic opportunities / Anastasia Constantinidou, Robin L. Jones & Jorge S. Reis-Filho -- Molecular profile of triple-negative breast cancer / Leonel F. Hernandez-Aya & Ana Maria Gonzalez-Angulo -- Role of metabolic rehabilitation-based approach in TNBC : biguanide metformin and more / Lev M. Berstein, Garik A. Dashyan & Vladimir F. Semiglazov -- Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer / Mark Robson -- Targeted therapies: EGFR inhibitors / Farrah M. Datko & Maura N. Dickler -- Targeted therapies : other agents in clinical trials / Brian R. Haney, Nathan M. Shumway & George E. Peoples -- Combined therapies and future directions / Anastasia Pazaiti & Ian S. Fentiman | ||
| 650 | 4 | |a Breast / Cancer | |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 653 | |a Electronic books | ||
| 689 | 0 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Hudis, Clifford A. |e Sonstige |0 (DE-588)1013370384 |4 oth | |
| 856 | 4 | 0 | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840123 |x Verlag |3 Volltext |
| 912 | |a ZDB-81-FSG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024696788 | ||
| 966 | e | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840123 |l UBR01 |p ZDB-81-FSG |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804148767109152768 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)1013370384 |
| building | Verbundindex |
| bvnumber | BV039836806 |
| classification_rvk | XH 8465 |
| collection | ZDB-81-FSG |
| ctrlnum | (OCoLC)759716165 (DE-599)BVBBV039836806 |
| dewey-full | 616.99/449 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/449 |
| dewey-search | 616.99/449 |
| dewey-sort | 3616.99 3449 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02635nmm a2200457zc 4500</leader><controlfield tag="001">BV039836806</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20121029 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">120124s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840123</subfield><subfield code="c">eBook</subfield><subfield code="9">978-1-78084-012-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840130</subfield><subfield code="9">978-1-78084-013-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2217/9781780840123</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)759716165</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039836806</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/449</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8465</subfield><subfield code="0">(DE-625)152958:13144</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in the management of triple negative breast cancer</subfield><subfield code="c">editors, Clifford A. Hudis ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Future Medicine Ltd</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic text (107 p.)</subfield><subfield code="b">col. ill., digital file</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Future Science Group eBook collection</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Advances in the management of triple-negative breast cancer / Tiffany A. Traina & Clifford A. Hudis -- Etiology and risk factors / Laura Fejerman & Elad Ziv -- Diagnosis and pathology / Govardhanan Nagaiah & Jame Abraham -- Molecular subtypes and emerging therapeutic opportunities / Anastasia Constantinidou, Robin L. Jones & Jorge S. Reis-Filho -- Molecular profile of triple-negative breast cancer / Leonel F. Hernandez-Aya & Ana Maria Gonzalez-Angulo -- Role of metabolic rehabilitation-based approach in TNBC : biguanide metformin and more / Lev M. Berstein, Garik A. Dashyan & Vladimir F. Semiglazov -- Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer / Mark Robson -- Targeted therapies: EGFR inhibitors / Farrah M. Datko & Maura N. Dickler -- Targeted therapies : other agents in clinical trials / Brian R. Haney, Nathan M. Shumway & George E. Peoples -- Combined therapies and future directions / Anastasia Pazaiti & Ian S. Fentiman</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast / Cancer</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hudis, Clifford A.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1013370384</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840123</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-81-FSG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024696788</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840123</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-81-FSG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV039836806 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:12:22Z |
| institution | BVB |
| isbn | 9781780840123 9781780840130 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024696788 |
| oclc_num | 759716165 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 electronic text (107 p.) col. ill., digital file |
| psigel | ZDB-81-FSG |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Future Medicine Ltd |
| record_format | marc |
| series2 | Future Science Group eBook collection |
| spelling | Advances in the management of triple negative breast cancer editors, Clifford A. Hudis ... London Future Medicine Ltd c2011 1 electronic text (107 p.) col. ill., digital file txt rdacontent c rdamedia cr rdacarrier Future Science Group eBook collection Includes bibliographical references and index Advances in the management of triple-negative breast cancer / Tiffany A. Traina & Clifford A. Hudis -- Etiology and risk factors / Laura Fejerman & Elad Ziv -- Diagnosis and pathology / Govardhanan Nagaiah & Jame Abraham -- Molecular subtypes and emerging therapeutic opportunities / Anastasia Constantinidou, Robin L. Jones & Jorge S. Reis-Filho -- Molecular profile of triple-negative breast cancer / Leonel F. Hernandez-Aya & Ana Maria Gonzalez-Angulo -- Role of metabolic rehabilitation-based approach in TNBC : biguanide metformin and more / Lev M. Berstein, Garik A. Dashyan & Vladimir F. Semiglazov -- Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer / Mark Robson -- Targeted therapies: EGFR inhibitors / Farrah M. Datko & Maura N. Dickler -- Targeted therapies : other agents in clinical trials / Brian R. Haney, Nathan M. Shumway & George E. Peoples -- Combined therapies and future directions / Anastasia Pazaiti & Ian S. Fentiman Breast / Cancer Brustkrebs (DE-588)4008528-4 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Electronic books Brustkrebs (DE-588)4008528-4 s Therapie (DE-588)4059798-2 s DE-604 Hudis, Clifford A. Sonstige (DE-588)1013370384 oth http://www.futuremedicine.com/doi/book/10.2217/9781780840123 Verlag Volltext |
| spellingShingle | Advances in the management of triple negative breast cancer Breast / Cancer Brustkrebs (DE-588)4008528-4 gnd Therapie (DE-588)4059798-2 gnd |
| subject_GND | (DE-588)4008528-4 (DE-588)4059798-2 |
| title | Advances in the management of triple negative breast cancer |
| title_auth | Advances in the management of triple negative breast cancer |
| title_exact_search | Advances in the management of triple negative breast cancer |
| title_full | Advances in the management of triple negative breast cancer editors, Clifford A. Hudis ... |
| title_fullStr | Advances in the management of triple negative breast cancer editors, Clifford A. Hudis ... |
| title_full_unstemmed | Advances in the management of triple negative breast cancer editors, Clifford A. Hudis ... |
| title_short | Advances in the management of triple negative breast cancer |
| title_sort | advances in the management of triple negative breast cancer |
| topic | Breast / Cancer Brustkrebs (DE-588)4008528-4 gnd Therapie (DE-588)4059798-2 gnd |
| topic_facet | Breast / Cancer Brustkrebs Therapie |
| url | http://www.futuremedicine.com/doi/book/10.2217/9781780840123 |
| work_keys_str_mv | AT hudisclifforda advancesinthemanagementoftriplenegativebreastcancer |